Pay for plasma collection coming to Alberta by end of the year

14 February 2021 - Repeal of NDP bill last fall clears way for Canadian Plasma Resources to set up shop. ...

Read more →

Platelet rich plasma treatment is not classified as a drug, Health Canada says

27 July 2019 - Agency clarifies its position on controversial treatment made popular by superstar athletes. ...

Read more →

Esperoct is now approved in Canada for the treatment of haemophilia A in both children and adults

12 July 2019 - New treatment can help Canadians living with haemophilia A better manage their bleeding episodes ...

Read more →

Health Canada has now authorised Adynovate [anti-haemophilic factor (recombinant), PEGylated] in paediatrics for treatment of children under 12 with haemophilia A

26 November 2018 - Canadian children now have access to Adynovate, which offers a twice-weekly prophylaxis dosing schedule and on-demand control ...

Read more →

Bayer receives approval for haemophilia A treatment Jivi

24 October 2018 - Extended half-life product that offers a reduction in dosing frequency and improved bleeding protection. ...

Read more →

Berinert approved by Health Canada for the treatment of hereditary angioedema in paediatric patients

9 August 2017 - CSL Behring is pleased to announce that on 31 March 2017 Berinert (C1 esterase inhibitor, human) was ...

Read more →

Health Canada approves CSL Behring’s Afstyla for the treatment of haemophilia A

14 December 2016 - Afstyla is the first and only single-chain recombinant factor VIII for haemophilia A, specifically designed for ...

Read more →